Skip to main content
Clinical Trials/NCT05030883
NCT05030883CompletedNot Applicable

The Effect of Source Type and Protective Message on the Critical Evaluation of News Messages on Facebook: An Experimental Study in the Netherlands.

Tilburg University1 site in 1 country400 target enrollmentStarted: May 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
400
Locations
1
Primary Endpoint
Critical evaluation of source and news

Study Overview

Brief Summary

Background: Disinformation has become an increasing societal concern, especially due to the speed that news is shared in the current digital era. In particular in the healthcare sector disinformation can lead to serious casualties, as the current COVID-19 crisis clearly shows.

Objective: The main aim of this study was to experimentally examine the effects of information about the source's and a displayed protective warning message on users' critical evaluation of news items, as well as the perception of accuracy of the news item.

Methods: A 3(unreliable versus reliable versus no identified source) x 2 (protective message: with versus without) between subject design has been conducted among 307 participants (mean age = 29 years, SD = 10.9 years).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Facebook user
  • older than 18

Exclusion Criteria

  • younger than 18 years
  • no facebook

Outcomes

Primary Outcomes

Critical evaluation of source and news

Time Frame: immediately after exposure, 5 minutes

questionnaire

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Tilburg University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Frans Folkvord

Assistant professor

Tilburg University

Study Sites (1)

Loading locations...

Similar Trials